Clinical Trials Directory

Trials / Completed

CompletedNCT01734473

Casein Protein and Leucine Supplementation in Chronic Obstructive Pulmonary Disease (COPD)

Casein Protein and Leucine Supplementation to Induce Anabolism in COPD Patients and Healthy Elderly

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
36 (actual)
Sponsor
Texas A&M University · Academic / Other
Sex
All
Age
45 Years
Healthy volunteers
Accepted

Summary

Weight loss commonly occurs in patients with COPD, negatively influencing their quality of life, treatment response and survival. Loss of muscle protein is generally a central component of this weight loss and independently increases mortality. This study will provide relevant clinical information in regards to the anabolic properties of specific dietary substrates and their co-active anabolic effects. Hypotheses: 1) That supplementation of a hydrolyzed casein-based protein meal with the addition of carbohydrates is more anabolic than a hydrolyzed casein-based protein meal without carbohydrates in COPD patients and healthy older adults; 2) That leucine addition to a hydrolyzed casein-based protein meal only enhances the protein anabolic response in COPD patients and healthy older adults when carbohydrates are not added to the protein meal; 3) That COPD patients have a more efficient protein anabolic response to a hydrolyzed casein-based protein meal than healthy older adults. A fifth study day was added to measure protein requirements of included individuals to be able to interpret their response to the other interventions on the other study days, and to test the hypothesis that subjects with lower protein requirements respond less to intervention with leucine and/or carbohydrates. For the 5th additional test day we will first approach the 10 COPD and 10 healthy subjects who already completed the first 4 study days (and signed the re-contact form) to come back for this extra test day. We will (pre-)screen these subjects by phone for eligibility and check for changes in their recent medical history (with help of the (pre-)screening questionnaires in CRF). If all inclusion criteria are still met, these subjects will be asked to provide a written re-consent. If necessary, we will recruit new subjects who will complete only one of the four test days (i.e. the test day on which the hydrolyzed casein-based protein meal with carbohydrates is provided) and the additional 5th study day.

Detailed description

The study involves 5 study days. The duration of the first 4 study days is approximately 6.5 hours per day and the duration of the 5th study day is approximately 8 hours. On each of the first 4 study days the effect a casein protein meal with or without leucine and carbohydrates will be examined. On the fifth study day the effect of 4 different levels of casein protein and carbohydrate intake by sip feeding (every 20 minutes) is examined. Also, subjects will receive a mixture of amino acids (little parts of protein) which are a little bit heavier than normal, called stable isotopes. This is the so-called stable isotope method to investigate protein behavior in the body (protein kinetics). Altogether about 75 ml of blood will be drawn per study day to assess outcome measures.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTHydrolyzed casein proteinAmount provided is based on the fat-free mass of subject
DIETARY_SUPPLEMENTHydrolyzed casein protein + carbohydratesAmount provided is based on the fat-free mass of subject
DIETARY_SUPPLEMENTHydrolyzed casein protein + leucineAmount provided is based on the fat-free mass of subject. Leucine (40% of essential amino acid content)
DIETARY_SUPPLEMENTHydrolyzed casein protein + carbohydrates + leucineAmount provided is based on the fat-free mass of subject. Leucine (40% of essential amino acid content)
DIETARY_SUPPLEMENT4 levels of hydrolyzed casein protein + carbohydratesAmount provided is based on the fat-free mass of subject. The 4 levels are: 0, 0.02, 0.05, 0.15 g casein protein/kg fat free mass/hr. The ratio between protein and carbohydrates is fixed.

Timeline

Start date
2012-11-28
Primary completion
2015-05-27
Completion
2015-05-27
First posted
2012-11-27
Last updated
2025-09-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01734473. Inclusion in this directory is not an endorsement.